WHO updates guidelines for testing, diagnosis and treatment of Hepatitis B and C

Organisation: Position: Deadline Date: Location:

The first World Health Organisation (WHO) guidelines on testing for chronic HBV and HCV infection have been released.

Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic.

Early identification of persons with chronic HBV or HCV infection enables them to receive the necessary care and treatment to prevent or delay progression of liver disease. Testing also provides an opportunity to link people to interventions to reduce transmission, through counselling on risk behaviours and provision of prevention commodities (such as sterile needles and syringes) and hepatitis B vaccination.

These are the first World Health Organisation (WHO) guidelines on testing for chronic HBV and HCV infection and complement published guidance by the WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection.

These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.

World Health Organisation material
World Health Organisation guidelines


Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.